SLC6A3 and major depressive disorder: Our main findings are that there is no difference in striatal D2/3 receptor and transporter availability in MDD compared to healthy controls when all tracers were included, but DAT availability was significantly lower in the MDD group after excluding studies using tracers with appreciable affinity for serotonin transporters.